Cleared Special

QUICK VUE INFLUENZA

K131599 · Quidel Corporation · Microbiology
Jul 2013
Decision
32d
Days
Class 1
Risk

About This 510(k) Submission

K131599 is an FDA 510(k) clearance for the QUICK VUE INFLUENZA, a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX), submitted by Quidel Corporation (San Diego, US). The FDA issued a Cleared decision on July 5, 2013, 32 days after receiving the submission on June 3, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K131599 FDA.gov
FDA Decision Cleared SESE
Date Received June 03, 2013
Decision Date July 05, 2013
Days to Decision 32 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3330

Similar Devices — GNX Antigens, Cf (including Cf Control), Influenza Virus A, B, C

All 17
ALERE BINAXNOW INFLUENZA A & B CARD
K133411 · Alere Scarborough, Inc D/B/A Binax, Inc. · Dec 2013
SAS FLUALERT A & B, SAS INFLUENZA A TEST
K132352 · Sa Scientific , Ltd. · Aug 2013
REMEL XPECT FLU A&B
K131804 · Remel, Inc. · Jul 2013
SOFIA INFLUENZA A+B FIA
K131606 · Quidel Corp. · Jul 2013
QUICKVUE INFLUENZA A+B
K131619 · Quidel Corp. · Jun 2013
OSOM INFLUENZA A&B TEST MODEL 190
K123182 · SEKISUI Diagnostics, LLC · Nov 2012